Записаться - т. (495)-933-66-55

Терапевт - главная ›› Для врачей ›› Подагра


1  . . .7 8 9 10 11 12 13 14 15 . . .22 

ncbi.nlm.nih.gov/pmc/articles/PMC1001355/" target="_blank">[Full Text].

  • Choi HK, De Vera MA, Krishnan E. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology (Oxford). Oct 2008;47(10):1567-70. [Medline].

  • Olaniyi-Leyimu BY. Consider gout in patients with risk factors, regardless of age. Am Fam Physician. Jul 15 2008;78(2):176. [Medline].

  • Yarom A, Rennebohm RM, Strife F, Levinson JE. Juvenile gouty arthritis. Two cases associated with mild renal insufficiency. Am J Dis Child. Oct 1984;138(10):955-7. [Medline].

  • Singh H, Torralba KD. Therapeutic challenges in the management of gout in the elderly.Geriatrics. Jul 2008;63(7):13-8, 20. [Medline].

  • Schumacher HR, Taylor W, Joseph-Ridge N, Perez-Ruiz F, Chen LX, Schlesinger N, et al. Outcome evaluations in gout. J Rheumatol. Jun 2007;34(6):1381-5. [Medline].

  • Becker MA, MacDonald PA, Hunt BJ, Lademacher C, Joseph-Ridge N. Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy. Nucleosides Nucleotides Nucleic Acids. Jun 2008;27(6):585-91. [Medline].

  • Yü T, Talbott JH. Changing trends of mortality in gout. Semin Arthritis Rheum. Aug 1980;10(1):1-9. [Medline].

  • Forman JP, Choi H, Curhan GC. Uric acid and insulin sensitivity and risk of incident hypertension.Arch Intern Med. Jan 26 2009;169(2):155-62. 

  • comments powered by Disqus